Microscopic medical robots are emerging as a breakthrough in biomedicine, with experts identifying in-vivo micro robotics as the next frontier after AI-driven drug development.
Magnetically controlled, flexible devices can navigate the human body through minimally invasive entry points to perform tasks such as clot removal, tissue sampling, targeted drug delivery, and in-body imaging—capabilities beyond conventional surgery.
At this year’s MEDTEX forum, micro robotics and AI drug discovery were highlighted as key themes. Industry leaders emphasized efforts to combine global innovation with Taiwan’s engineering and clinical strengths to develop scalable medical technologies.
Recent advances include ultra-flexible vascular robots capable of remote-controlled procedures, improving precision while reducing tissue damage. In 2025, the technology achieved a milestone with the first cross-continental remote thrombectomy trial.
